Synonyms: MRX-1 | MRX-I | Youxitai®
contezolid is an approved drug (China (2021))
Compound class:
Synthetic organic
Comment: Contezolid is an oxazolidinone antibacterial against Gram-positive pathogens [1], including methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae, penicillin-intermediate S. pneumoniae (PISP), and vancomycin-resistant enterococci (VRE). Its orally delivered prodrug is contezolid acefosamil (parent) (MRX-4). Contezolid targets protein synthesis by binding to the V region of the bacterial 23S rRNA.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (China (2021)) |
Prodrug | contezolid acefosamil (parent) |
IUPAC Name |
(5S)-5-[(1,2-oxazol-3-ylamino)methyl]-3-[2,3,5-trifluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidin-2-one |
International Nonproprietary Names | |
INN number | INN |
10775 | contezolid |
Synonyms |
MRX-1 | MRX-I | Youxitai® |
Database Links | |
Specialist databases | |
Antibiotic DB | Contezolid (MRX-4/MRX-1) |
Other databases | |
BindingDB Ligand | 50017203 |
CAS Registry No. | 1112968-42-9 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3287379 |
GtoPdb PubChem SID | 405560236 |
PubChem CID | 25184541 |
RCSB PDB Ligand | ZC0 |
Search Google for chemical match using the InChIKey | SULYVXZZUMRQAX-NSHDSACASA-N |
Search Google for chemicals with the same backbone | SULYVXZZUMRQAX |
Search PubMed clinical trials | contezolid |
Search PubMed titles | contezolid |
Search PubMed titles/abstracts | contezolid |
UniChem Compound Search for chemical match using the InChIKey | SULYVXZZUMRQAX-NSHDSACASA-N |
UniChem Connectivity Search for chemical match using the InChIKey | SULYVXZZUMRQAX-NSHDSACASA-N |